Jesse Lyle Goodman MD MPH
Transplant/Immunocompromised States, International Health, Travel & Tropical
Professor, Medicine, Georgetown University SOM
Join to View Full Profile
3800 Reservoir RdWashington, DC 20007
Dr. Goodman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 1983 - 1985- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1983
University of Pennsylvania Health SystemResidency, Internal Medicine, 1977 - 1979
Albert Einstein College of MedicineClass of 1977
Harvard UniversityAB, Biology, 1969 - 1973
Certifications & Licensure
DC State Medical License 2003 - 2027
MN State Medical License 1986 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsPrepare now for a potential H5N1 pandemic.Jesse L Goodman, Norman W Baylor, Rebecca Katz, Lawrence O Gostin, Rick A Bright
Science. 2025-03-07 - H5 Influenza Vaccines-Moving Forward Against Pandemic Threats.Jesse L Goodman, Rick A Bright, Nicole Lurie
JAMA. 2024-11-19 - 11 citationsReview and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa.Danielle M Venne, David M Hartley, Marissa D Malchione, Michala Koch, Anjali Y Britto
Antimicrobial Resistance and Infection Control. 2023-04-04
Authored Content
- Review and Mapping of Carbapenem-Resistant Enterobacteriaceae in Africa: Using Diverse Data to Inform Surveillance GapsJune 2018
Press Mentions
FDA Creates Hurdles for Americans to Get COVID-19 Vaccine, Puts Infants at Risk with Changes to Hepatitis-B Vaccine RecommendationsDecember 9th, 2025- What Are Adjuvants in Vaccines?December 4th, 2025
- FDA Official Proposes ‘Impossible’ Standards for Vaccine Testing That Could Curtail Access to ImmunizationsDecember 1st, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
